HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Minicore Myopathy with External Ophthalmoplegia

associated with mutations in RYR1
Also Known As:
Minicore Disease; Minicore Myopathy; Multi-Minicore Disease; Multicore Disease; Multicore Myopathy; Multicore Myopathy With External Ophthalmoplegia; Multiminicore Disease; Multiminicore Disease With External Ophthalmoplegia; Multiminicore Myopathy
Networked: 66 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Related Diseases

1. Central Core Myopathy (Central Core Disease)
2. Congenital Structural Myopathies (Centronuclear Myopathy)
3. Muscular Diseases (Myopathy)
4. Malignant Hyperthermia
5. Muscular Dystrophies (Muscular Dystrophy)

Experts

1. Muntoni, Francesco: 11 articles (01/2019 - 10/2002)
2. Treves, Susan: 10 articles (01/2020 - 10/2005)
3. Jungbluth, Heinz: 10 articles (01/2019 - 06/2002)
4. Zorzato, Francesco: 9 articles (01/2020 - 10/2005)
5. Ferreiro, Ana: 6 articles (05/2008 - 06/2002)
6. Pegoraro, Elena: 4 articles (01/2022 - 01/2018)
7. Jungbluth, H: 4 articles (07/2015 - 10/2004)
8. Sewry, Caroline A: 4 articles (12/2011 - 12/2004)
9. Nishino, Ichizo: 3 articles (10/2021 - 06/2006)
10. Bachmann, Christoph: 3 articles (01/2020 - 01/2019)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Minicore Myopathy with External Ophthalmoplegia:
1. Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
2. Selenoproteins (Selenoprotein)IBA
3. EnzymesIBA
4. Proteins (Proteins, Gene)FDA Link
5. CalciumIBA
6. ConnectinIBA
7. Protein Isoforms (Isoforms)IBA
8. Anesthetics (Anesthetic Agents)IBA
9. AMP Deaminase (Myoadenylate Deaminase)IBA
10. FilaminsIBA

Therapies and Procedures

1. Anesthesia
2. Anesthesia and Analgesia